使用JenaValve在患有隔离性主动脉的患者中植入导管主动脉
The Journal of international medical research
|September 5, 2025
概括
在高风险患者中,使用JenaValve进行过导管大动脉植入成功治疗严重的大动脉吐. 这种微创手术改善了心脏功能,
科学领域:
- 心血管医学
- 干预心脏病学
- 医疗设备技术
背景情况:
- 严重的主动脉吐带来很大的风险,特别是在患有慢性脏病和心力衰竭等并发症的患者中.
- 由于手术风险增加,传统的动脉置换在高危患者中可能是禁忌的.
- 在复杂的心血管病例中,通过导管进行大动脉植入 (TAVI) 是一种潜在的替代方案.
研究的目的:
- 报告JenaValve系统通过导管植入大动脉的成功应用.
- 评估TAVI在患有严重主动脉吐和多种并发症的患者的疗效和安全性.
- 突出先进的TAVI设备在高风险手术患者的管理中的潜力.
主要方法:
- 一个病例报告详细介绍了一位50多岁的男性患者的TAVI手术.
- 使用了第二代TAVI设备JenaValve,
- 评估了手术后的立即结果,包括心脏功能和门能力.
主要成果:
- 心脏功能立即得到改善.
- 植入后没有显著的主动脉吐或漏.
- 这项程序耐受良好,证明了TAVI在复杂的患者形状中的可行性.
结论:
- 在高风险患者中,通过导管植入主动脉是一种可行的有效治疗方法.
- 在TAVI设备的技术进步正在扩大复杂的心血管疾病的治疗选择.
- 多学科方法和长期随访对于优化TAVI后患者的结果至关重要.
相关概念视频
Aortic Regurgitation III: Medical Management
39
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
39
Aortic Regurgitation IV: Nursing Management
52
A nurse managing a patient with aortic regurgitation begins with a comprehensive assessment, including a review of the patient's medical history, family history, and lifestyle factors. During the cardiac examination, the nurse listens for heart sounds and checks for signs of valve abnormalities. The nurse also observes for symptoms such as dyspnea, orthopnea, and paroxysmal nocturnal dyspnea and assesses the patient's endurance and daily activity tolerance.Based on the findings, the nurse...
52
Aortic Regurgitation I: Introduction
35
IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
35
Mitral Regurgitation III: Medical Management
27
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
27
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
51
Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
51
Mitral Regurgitation I: Introduction
53
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
53


